By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sirna Therapeutics, Inc. 

A Wholly Owned Subsidiary Of Merck & Co., Inc.
1700 Owens Street, 4th Floor
San Francisco  California  94158  U.S.A.
Phone: 415-512-7200 Fax: 415-512-7022


SEARCH JOBS


Industry
Biotechnology






Company News
Alnylam Pharmaceuticals (ALNY) Announces Closing Of Previously Announced Acquisition Of Merck & Co., Inc. (MRK)'s Sirna Therapeutics, Inc. (RNAI) Subsidiary 3/6/2014 9:46:12 AM
Alnylam Pharmaceuticals (ALNY) Ponies Up $175 Million Upfront For Merck & Co., Inc. (MRK)'s Sirna Therapeutics, Inc. (RNAI) 1/12/2014 8:43:59 PM
Biotech Blossoms Anew 4/29/2008 4:47:53 PM
Protiva Biotherapeutics: California Superior Court Grants Preliminary Injunction Prohibiting Sirna Therapeutics, Inc. (RNAI) From Using Protiva Technology 4/16/2007 10:25:06 AM
Sirna Therapeutics, Inc. (RNAI) Shareholders Approve Acquisition By Merck & Co., Inc. (MRK) 12/28/2006 3:05:19 PM
Merck & Co., Inc. (MRK) And Sirna Therapeutics, Inc. (RNAI) Announce Expiration Of Hart-Scott-Rodino Waiting Period For The Proposed Acquisition Of Sirna By Merck 12/14/2006 11:05:40 AM
Sirna Therapeutics, Inc. (RNAI) Reports Third Quarter 2006 Financial Results 11/14/2006 12:57:53 PM
Sirna Therapeutics, Inc. (RNAI) To Present At 2006 Biotechnology Industry Organization (BIO) InvestorForum 10/11/2006 11:50:20 AM
Sirna Therapeutics, Inc. (RNAI) To Present At UBS Warburg Global Life Sciences Conference 9/18/2006 2:44:24 PM
Sirna Therapeutics, Inc. (RNAI) To Present At BioJapan 2006 World Business Forum 9/11/2006 9:57:00 AM
1234567
//-->